The index is predicted to attain a target of 11,850 and 12,000, thereby offering investors and traders an opportunity to profit from the market. It is recommended to purchase the index at the current market price or during any subsequent dips while keeping the target of 11,850 and 12,000 in mind.
It is also suggested that a stop loss be maintained below 11,630 on a closing basis, in order to minimise risks associated with the investment.
The technical indicator, Stohastic, further reinforces the idea that the Nifty Pharma Index is expected to exhibit superior performance in the near term. It is advised that traders and investors be vigilant and stay abreast of market movements to make informed decisions.
Overall, the Nifty Pharma Index is a lucrative investment option with the potential for significant gains.
However, the index recently witnessed a breakout, with a slight pullback to back up this trend. Technical indicators such as the RSI, PSR, and Bollinger Bands all favor the notion that bullish trends are likely to surpass bearish ones.
It is recommended that traders and investors purchase the Nifty Oil & Gas Index and its constituents at the current market price or during any subsequent dips, with a minimum target of 7,410 and 7,525 in mind.
It is also advised that a stop loss of close below 7,000 be maintained in order to minimise risks associated with the investment.
Overall, the Nifty Oil & Gas Index presents itself as a potentially lucrative investment opportunity, with technical indicators pointing towards a bullish trend.
(Ravi Nathani is an independent technical analyst. Views expressed are personal).
One subscription. Two world-class reads.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Access to Exclusive Premium Stories
Over 30 subscriber-only stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app